Abstract
This chapter covers several items which are related only in that they are unusual; that explains the title. Two of these involve absorption kinetics, while the others involve disposition.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R.F. Bergstrom, D.R. Kay and J.G. Wagner, High-performance liquid chromatographic determination of penicillamine in whole blood, plasma and urine, J. Chromatogr. 222: 445–452 (1981).
R.F. Bergstrom, D.R. Kay and J.G. Wagner, Thein vitroloss of penicillamine in plasma, albumin solutions, and whole blood: Implications for pharmacokinetic studies of penicillamine, Life Sci. 27: 189–198 (1980).
R.F. Bergstrom, D.R. Kay, T.M. Harkcom and J.G. Wagner, Penicillamine kinetics in normal subjects, Clin. Pharmacol. Ther. 30: 404–413 (1981).
M. Weinberger, L. Hendeles and L. Bighley, The relation of product formulation to absorption of oral theophylline, N. Engl. J. Med. 299: 852–857 (1978).
J.G. Wagner and E. Nelson, Percent absorbed time plots derived from blood level and/or urinary excretion data, J. Pharm. Sci. 52: 610–611 (1963).
J.G. Wagner, Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data, J. Pharmacokin. Biopharm. 4: 443–467 (1976).
J.G. Wagner, K.D. Popat, S.K. Das, E. Sakmar and H. Movahhed, Evidence of nonlinearity in digoxin pharmacokinetics, J. Pharmacokin. Biopharm. 9: 147–166 (1981).
J.G. Wagner, M.R. Hallmark, E. Sakmar and J.W. Ayres, Sensitive radioimmunoassay for digoxin in plasma and urine, Steroids 29: 787–807 (1977).
J.A. Morais, R.A. Zlotecki, E.Sakmar, P.L. Stetson and J.G. Wagner, Specific and sensitive assays for digoxin in plasma, urine and heart tissue, Res. Commun. Chem. Path. Pharmacol. 31: 285–298 (1981).
D.J. Weidler, N.S. Jallad, K.L. Black and J.G. Wagner, Alteration of pharmacokinetic parameters for pentobarbital by ischemic stroke and reversion to normal by dexamethasone treatment, J. Clin. Pharmacol. 20: 543–551 (1980).
J.L. Anderson, E. Patterson, J.G. Wagner, J.R. Stewart, H.L. Behm and B.R. Lucchesi, Oral and intravenous bretylium disposition, Clin. Pharmacol. Ther. 28: 408–478 (1980).
. J.L. Anderson, E. Patterson, J.G. Wagner, T.A. Johnson, B.R. Lucchesi and B. Pitt, Clinical pharmacokinetics of intravenous and oral bretylium tosylate in survivors of ventricular tachycardia or fibrillation: Clinical application of a new assay for bretylium, J. Cardiovasc. Pharmacol. 3: 485–499 (1981).
K.C. Kwan and A.E. Till, Novel method for bioavailability assessment, J. Pharm. Sci. 62: 1494–1497 (1973).
J.G. Wagner, A.R. DiSanto, W.R. Gillespie and K.S. Albert, Reversible metabolism and pharmacokinetics: Application to prednisone-prednisolone, Res. Commun. Chem. Path. Pharmacol. 32: 387–406 (1981).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Plenum Press, New York
About this chapter
Cite this chapter
Wagner, J.G. (1984). Unusual Pharmacokinetics. In: Benet, L.Z., Levy, G., Ferraiolo, B.L. (eds) Pharmacokinetics. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2799-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2799-8_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9725-3
Online ISBN: 978-1-4613-2799-8
eBook Packages: Springer Book Archive